Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) RegistryJoanna Góra-Tybor, Krzysztof Jamroziak, Tomasz Sacha et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 2
Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) RegistryJoanna Góra‐Tybor, Krzysztof Jamroziak, Aleksandra Gołoś et al.|Blood|2019Cited by 0